SEC Form 4 · accession 0001209191-18-025306
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah Boyce
Officer — President · Director
Period of report
Apr 17, 2018
Accepted (ET)
Apr 18, 2018 · 1:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 17, 2018 | A | 20,894 | $0.00 | A | 20,894 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $23.93 | Apr 17, 2018 | A | 1,000,000 | A | — | Apr 16, 2028 | Common Stock | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1The shares vest as follows: 1/4th of the shares vest one year after April 17, 2018;1/48th of the shares vest monthly thereafter over the next three years.